Transparency-Rx’s Post

"The job of the P.B.M.s is to reduce drug costs. Instead, they frequently do the opposite." That's from this morning's The New York Times front-page article; it's an incredible read on the #PharmacyBenefitManagement industry based on what appears to be exceptional due diligence. For six years, we've been battling the "status quo" traditional PBM business model's opacity and misaligned incentives, which have thrived at the expense of payers and patients despite clear warnings. If you've ever heard A. J. Loiacono, Ryan Kelly, Kristin Begley, PharmD, et al. speak at conferences, on webinars, or at finalist meetings, then you know why we're saying, "Thank you, Rebecca Robbins and Reed Abelson, for highlighting how clear and present many of the issues remain, as well as the real impact they have on America's healthcare consumers." #PharmacyBenefitAdministration #AlignmentMatters #DrugPrices #HealthCareCosts Check out the article here: https://okt.to/4DdjPJ

"The job of the P.B.M.s is to reduce drug costs. Instead, they frequently do the opposite." That's from this morning's The New York Times front-page article; it's an incredible read on the #PharmacyBenefitManagement industry based on what appears to be exceptional due diligence. For six years, we've been battling the "status quo" traditional PBM business model's opacity and misaligned incentives, which have thrived at the expense of payers and patients despite clear warnings. If you've ever heard A. J. Loiacono, Ryan Kelly, Kristin Begley, PharmD, et al. speak at conferences, on webinars, or at finalist meetings, then you know why we're saying, "Thank you, Rebecca Robbins and Reed Abelson, for highlighting how clear and present many of the issues remain, as well as the real impact they have on America's healthcare consumers." #PharmacyBenefitAdministration #AlignmentMatters #DrugPrices #HealthCareCosts Check out the article here: https://okt.to/mHtyEu

By making your members feel valued and important, you can unlock a range of benefits that extend far beyond just participation. When members feel heard and cared for, they are more likely to engage with the programs designed to support them, leading to: 1- Lower pharmacy costs 2- Improved health outcomes for members 3- Increased trust and loyalty between members and their PBM 4- More informed healthcare decisions by members At DisclosedRx, we understand the critical role that member engagement plays in driving the success of Specialty Drug assistance programs. By focusing on building strong, trusting relationships with our members, we can help them navigate the complexities of managing their health while also achieving better outcomes for everyone involved. Ready to learn more about how prioritizing member engagement can transform your Specialty Drug assistance programs? Let's start the conversation today - message us on LinkedIn. #MemberEngagement #SpecialtyDrugAssistance #FiduciaryPBM #HealthcareOutcomes

By making your members feel valued and important, you can unlock a range of benefits that extend far beyond just participation. When members feel heard and cared for, they are more likely to engage with the programs designed to support them, leading to: 1- Lower pharmacy costs 2- Improved health outcomes for members 3- Increased trust and loyalty between members and their PBM 4- More informed healthcare decisions by members At DisclosedRx, we understand the critical role that member engagement plays in driving the success of Specialty Drug assistance programs. By focusing on building strong, trusting relationships with our members, we can help them navigate the complexities of managing their health while also achieving better outcomes for everyone involved. Ready to learn more about how prioritizing member engagement can transform your Specialty Drug assistance programs? Let's start the conversation today - message us on LinkedIn. #MemberEngagement #SpecialtyDrugAssistance #FiduciaryPBM #HealthcareOutcomes

By making your members feel valued and important, you can unlock a range of benefits that extend far beyond just participation. When members feel heard and cared for, they are more likely to engage with the programs designed to support them, leading to: 1- Lower pharmacy costs 2- Improved health outcomes for members 3- Increased trust and loyalty between members and their PBM 4- More informed healthcare decisions by members At DisclosedRx, we understand the critical role that member engagement plays in driving the success of Specialty Drug assistance programs. By focusing on building strong, trusting relationships with our members, we can help them navigate the complexities of managing their health while also achieving better outcomes for everyone involved. Ready to learn more about how prioritizing member engagement can transform your Specialty Drug assistance programs? Let's start the conversation today - message us on LinkedIn. #MemberEngagement #SpecialtyDrugAssistance #FiduciaryPBM #HealthcareOutcomes

By making your members feel valued and important, you can unlock a range of benefits that extend far beyond just participation. When members feel heard and cared for, they are more likely to engage with the programs designed to support them, leading to: 1- Lower pharmacy costs 2- Improved health outcomes for members 3- Increased trust and loyalty between members and their PBM 4- More informed healthcare decisions by members At DisclosedRx, we understand the critical role that member engagement plays in driving the success of Specialty Drug assistance programs. By focusing on building strong, trusting relationships with our members, we can help them navigate the complexities of managing their health while also achieving better outcomes for everyone involved. Ready to learn more about how prioritizing member engagement can transform your Specialty Drug assistance programs? Let's start the conversation today - message us on LinkedIn. #MemberEngagement #SpecialtyDrugAssistance #FiduciaryPBM #HealthcareOutcomes

DKI Health’s Jamie Culp and the National Bleeding Disorders Foundation's Philip Gattone presented “Amplifying Patient Voice in Market Access” at the 4th Chief Patient Officer Summit (#CPOSummit). What to know: • Health insurers are covering fewer drugs and making them harder to get. • New utilization management (UM) tactics emerge as payers and pharma fight over cost sharing: patients pay the heavy price. • Payers apply artificial intelligence (AI) to limit patient care—sometimes against clinician opinion and Medicare rules. • Drug access has been protected by patient advocacy in legislatures, courts, and prescription drug affordability boards (PDAB). Patients and advocates can be a difference-maker in winning and maintaining access—if we understand and address their needs. • NBDF’s Comprehensive Care Sustainability Collaborative shows the opportunity for collaboration with payers, providers, and patients to ensure treatment access. #DKImpact #patientvoice #marketaccess

Another passionate discussion about #policy #reforms to the #pharmacybenefitsmanager #pbm industry this morning at @TheHillEvents  #TheHillHealth. The key take-away for me: this is a very complex industry, and, despite bipartisan and bicameral support for legislative reform, an issue with a LOT of different viewpoints and proposed policy solutions. It is also an issue that directly impacts the health and economic wellbeing of patients and families across the country, with many #raredisease patients disproportionately impacted due to overall high healthcare utilization and many #orphandrugs on specialty tiers of the formulary. My sincere hope is that any reform package that may come together - this spring, later in the lame duck session, next year, or sometime in the more distant future - actually directly benefits our patients and families. It is just too easy for the true needs of the end-consumer to get lost in the debate. https://lnkd.in/gfkbqWAb

In this short video, discover the key findings identified during Tuesday's hearing on The Role of Pharmacy Benefit Managers in Prescription Drug Markets held by the House Committee on Oversight and Accountability. Watch AMCP Manager of Government Affairs, Tom Casey share insights managed care pharmacy professionals should have on their radar. https://bit.ly/46gNMdf #pbm #advocacy #healthcare #managedcare #pharmacy #pharmacists

Don’t miss this live webinar next week! Mark Cuban Cost Plus Drug Company, PBC & RxPreferred will discuss the complexities of the current pharmacy benefits landscape, unravel how traditional PBMs are impacting healthcare costs with limiting member accessibility, and the role transparency plays in reshaping the future of pharmacy benefits and patient care. Register today: https://zurl.co/CgoK Submit your questions for our hosts: questions@rxpreferred.com #PBM #transparency #healthcare